(Q31454903)

2 July 2017

title

Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS. (English)

1 reference

2 July 2017

Borth S

1

1 reference

2 July 2017

Hänsel W

series ordinal

2

1 reference

2 July 2017

Rösner P

series ordinal

3

1 reference

2 July 2017

Junge T

series ordinal

4

1 reference

2 July 2017

publication date

1 December 2000

1 reference

Forensic Science International

2 July 2017

published in

1 reference

2 July 2017

volume

114

1 reference

2 July 2017

issue

3

1 reference

2 July 2017

page(s)

139-153

1 reference

describes a project that uses

2 July 2017

gas chromatography-mass spectrometry

1 reference

Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Structure-activity relationships of BDB and its monomethyl and dimethyl derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Drug discrimination studies with MDMA and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2800%2900296-6

7 January 2021

10.1016/S0379-0738(00)00296-6

Identifiers

DOI

1 reference

2 July 2017

1 reference